[
  {
    "ts": "2026-01-09T09:00:00+00:00",
    "headline": "Bull of the Day: Eli Lilly (LLY)",
    "summary": "Eli Lilly has solidified itself as a global pharma titan. With leading drugs and a massive obesity market, Lilly is poised to be a juggernaut for years to come.",
    "url": "https://finance.yahoo.com/news/bull-day-eli-lilly-lly-090000015.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "466dad8b-f70b-355d-a1f2-27465d2b7109",
      "content": {
        "id": "466dad8b-f70b-355d-a1f2-27465d2b7109",
        "contentType": "STORY",
        "title": "Bull of the Day: Eli Lilly (LLY)",
        "description": "",
        "summary": "Eli Lilly has solidified itself as a global pharma titan. With leading drugs and a massive obesity market, Lilly is poised to be a juggernaut for years to come.",
        "pubDate": "2026-01-09T09:00:00Z",
        "displayTime": "2026-01-09T09:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/34e9e082846727ec8f9de30166d4e01c",
          "originalWidth": 620,
          "originalHeight": 300,
          "caption": "Zacks Investment Research",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/snPNf0X6c7oh8neoGyOvQQ--~B/aD0zMDA7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/34e9e082846727ec8f9de30166d4e01c.cf.webp",
              "width": 620,
              "height": 300,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BDWlpByoSGsIyaG28LOn9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/34e9e082846727ec8f9de30166d4e01c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bull-day-eli-lilly-lly-090000015.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bull-day-eli-lilly-lly-090000015.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "INCY"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T12:03:45+00:00",
    "headline": "Schrodinger to offer Eli Lilly's AI drug discovery platform on its software",
    "summary": "By Sneha S K Jan 9 (Reuters) - Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.",
    "url": "https://finance.yahoo.com/news/schrodinger-offer-eli-lillys-ai-120345241.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "060520a4-1d56-3754-8bce-293dd39e1a45",
      "content": {
        "id": "060520a4-1d56-3754-8bce-293dd39e1a45",
        "contentType": "STORY",
        "title": "Schrodinger to offer Eli Lilly's AI drug discovery platform on its software",
        "description": "",
        "summary": "By Sneha S K Jan 9 (Reuters) - Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.",
        "pubDate": "2026-01-09T12:03:45Z",
        "displayTime": "2026-01-09T12:03:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/f25a0702086183bacd7b8a1425d8e069",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.BsEyKXgL0C_78ZqRtxegQ--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f25a0702086183bacd7b8a1425d8e069.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GEhaigdd0AGTEFmsRHeIHQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f25a0702086183bacd7b8a1425d8e069.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/schrodinger-offer-eli-lillys-ai-120345241.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/schrodinger-offer-eli-lillys-ai-120345241.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T12:00:00+00:00",
    "headline": "Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign",
    "summary": "NEW YORK, January 09, 2026--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by providing access to advanced artificial intelligence (AI) capabilities. TuneLab will be made available in LiveDesign, Schrödinger’s widely used enterprise informatics platform, as a priority interface for participating biotech companies to access TuneLab workflows.",
    "url": "https://finance.yahoo.com/news/schr-dinger-partners-lilly-tunelab-120000797.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a140161a-0389-3466-b66f-b72e99a1bbf3",
      "content": {
        "id": "a140161a-0389-3466-b66f-b72e99a1bbf3",
        "contentType": "STORY",
        "title": "Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign",
        "description": "",
        "summary": "NEW YORK, January 09, 2026--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by providing access to advanced artificial intelligence (AI) capabilities. TuneLab will be made available in LiveDesign, Schrödinger’s widely used enterprise informatics platform, as a priority interface for participating biotech companies to access TuneLab workflows.",
        "pubDate": "2026-01-09T12:00:00Z",
        "displayTime": "2026-01-09T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/265dd09e6c994bd31c4ce58ff55d9e1a",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ulaQbaET.rVrDLn9Rzys_g--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/265dd09e6c994bd31c4ce58ff55d9e1a.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OPjeWDdPBAlw2_jlPQvstA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/265dd09e6c994bd31c4ce58ff55d9e1a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/schr-dinger-partners-lilly-tunelab-120000797.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/schr-dinger-partners-lilly-tunelab-120000797.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "SDGR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T09:45:00+00:00",
    "headline": "Eli Lilly and JD.com have been highlighted as Zacks Bull and Bear of the Day",
    "summary": "Eli Lilly's obesity drugs Mounjaro and Zepbound are driving explosive revenue growth, strengthening its dominance as demand accelerates worldwide.",
    "url": "https://finance.yahoo.com/news/eli-lilly-jd-com-highlighted-094500680.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "eb1e4ca3-cc85-3bc1-ba31-6403f741b331",
      "content": {
        "id": "eb1e4ca3-cc85-3bc1-ba31-6403f741b331",
        "contentType": "STORY",
        "title": "Eli Lilly and JD.com have been highlighted as Zacks Bull and Bear of the Day",
        "description": "",
        "summary": "Eli Lilly's obesity drugs Mounjaro and Zepbound are driving explosive revenue growth, strengthening its dominance as demand accelerates worldwide.",
        "pubDate": "2026-01-09T09:45:00Z",
        "displayTime": "2026-01-09T09:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-jd-com-highlighted-094500680.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-jd-com-highlighted-094500680.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "JD"
            },
            {
              "symbol": "BBAI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T13:00:43+00:00",
    "headline": "Demand For Google, Palantir Is Mere Peanuts Next To These 3 Stocks",
    "summary": "While AI stocks Google, Broadcom and Palantir remain in demand, the best mutual funds shoveled massive sums into 3 stocks.",
    "url": "https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-buy-google-broadcom-palantir-but-place-massive-bets-here/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "5671a2a6-3e87-3485-a124-b18fd9494254",
      "content": {
        "id": "5671a2a6-3e87-3485-a124-b18fd9494254",
        "contentType": "STORY",
        "title": "Demand For Google, Palantir Is Mere Peanuts Next To These 3 Stocks",
        "description": "",
        "summary": "While AI stocks Google, Broadcom and Palantir remain in demand, the best mutual funds shoveled massive sums into 3 stocks.",
        "pubDate": "2026-01-09T13:00:43Z",
        "displayTime": "2026-01-09T13:00:43Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/5671a2a6-3e87-3485-a124-b18fd9494254/demand-for-google-palantir.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/a69c2df9a4dcdcc84afcfbf2f71fc70d",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ydJQdAJgsCJcEKf8G_YUyw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/a69c2df9a4dcdcc84afcfbf2f71fc70d.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3gwaIitLsG3NkheXkN1Jzg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/a69c2df9a4dcdcc84afcfbf2f71fc70d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-buy-google-broadcom-palantir-but-place-massive-bets-here/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "SAN"
            },
            {
              "symbol": "PLUS"
            },
            {
              "symbol": "AIR"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GE"
            },
            {
              "symbol": "ASML"
            },
            {
              "symbol": "LRCX"
            },
            {
              "symbol": "RIO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T13:00:00+00:00",
    "headline": "Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models",
    "summary": "WALTHAM, Mass., January 09, 2026--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery.",
    "url": "https://finance.yahoo.com/news/revvity-collaborates-lilly-expand-access-130000963.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a2d177a0-e1b1-3ffb-9dfd-e5e5d9ddfbb7",
      "content": {
        "id": "a2d177a0-e1b1-3ffb-9dfd-e5e5d9ddfbb7",
        "contentType": "STORY",
        "title": "Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models",
        "description": "",
        "summary": "WALTHAM, Mass., January 09, 2026--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery.",
        "pubDate": "2026-01-09T13:00:00Z",
        "displayTime": "2026-01-09T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/36d5cdf9ed3c61a49a27a967eaf73629",
          "originalWidth": 784,
          "originalHeight": 320,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VIAQmKPhUw0Tb0iso8v4nQ--~B/aD0zMjA7dz03ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/36d5cdf9ed3c61a49a27a967eaf73629.cf.webp",
              "width": 784,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3Pv.KuW5Yu2ZKaJQlz5Jjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/36d5cdf9ed3c61a49a27a967eaf73629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revvity-collaborates-lilly-expand-access-130000963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revvity-collaborates-lilly-expand-access-130000963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "RVTY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]